Skip to main content
Log in

Neoadjuvante Behandlungskonzepte bei Borderline-resektablem Pankreaskarzinom

Neoadjuvant treatment concepts for borderline-resectable adenocarcinoma of the pancreas

  • Journal Club
  • Published:
Die Chirurgie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Ghaneh P, Palmer DH, Cicconi S et al (2020) ESPAC-5F: Four- arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer. J Clin Oncol 38(2020):abstr 4505

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Schneider MBA.

Ethics declarations

Interessenkonflikt

S. Roth und M. Schneider geben an, dass kein Interessenkonflikt besteht.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Roth, S., Schneider, M. Neoadjuvante Behandlungskonzepte bei Borderline-resektablem Pankreaskarzinom. Chirurgie 93, 995–996 (2022). https://doi.org/10.1007/s00104-022-01729-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00104-022-01729-1

Navigation